Literature DB >> 12214672

N-oxidation of drugs associated with idiosyncratic drug reactions.

Jack Uetrecht1.   

Abstract

Circumstantial evidence strongly suggests that most idiosyncratic drug reactions are due to reactive metabolites of drugs rather than due to the drugs themselves. Many of the drugs that are associated with idiosyncratic drug reactions contain nitrogen. There are many possible reasons for this association. One is simply that many drugs, especially CNS active drugs, contain nitrogen. In addition, nitrogen is relatively easy to oxidize because of its lone pair of electrons and many nitrogen-containing compounds readily undergo redox cycling, which can generate reactive oxygen species. There are several nitrogen-containing function groups that are especially associated with adverse reactions. These include aromatic amines, nitro compounds (nitro compounds are reduced to the same reactive intermediates as are formed by oxidation of the corresponding aromatic amine), hydrazines and compounds that can be oxidized to iminoquinone and related compounds. A greater attention to the issue of reactive metabolites during drug development would likely lead to safer drugs; however, not all drugs that form reactive metabolites are associated with a high incidence of idiosyncratic drug reactions. In addition to the presence of such a group, other factors, such as dose and electron density of the compound, appear to play a role in whether the drug containing such functional groups will be associated with a relatively high incidence of idiosyncratic drug reactions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12214672     DOI: 10.1081/dmr-120005667

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  5 in total

1.  Chemistry-Wide Association Studies (CWAS): A Novel Framework for Identifying and Interpreting Structure-Activity Relationships.

Authors:  Yen S Low; Vinicius M Alves; Denis Fourches; Alexander Sedykh; Carolina Horta Andrade; Eugene N Muratov; Ivan Rusyn; Alexander Tropsha
Journal:  J Chem Inf Model       Date:  2018-11-09       Impact factor: 4.956

Review 2.  Deleterious effects of reactive metabolites.

Authors:  Sabry M Attia
Journal:  Oxid Med Cell Longev       Date:  2010 Jul-Aug       Impact factor: 6.543

3.  The Metabolic Rainbow: Deep Learning Phase I Metabolism in Five Colors.

Authors:  Na Le Dang; Matthew K Matlock; Tyler B Hughes; S Joshua Swamidass
Journal:  J Chem Inf Model       Date:  2020-02-24       Impact factor: 4.956

4.  Cheminformatics-aided pharmacovigilance: application to Stevens-Johnson Syndrome.

Authors:  Yen S Low; Ola Caster; Tomas Bergvall; Denis Fourches; Xiaoling Zang; G Niklas Norén; Ivan Rusyn; Ralph Edwards; Alexander Tropsha
Journal:  J Am Med Inform Assoc       Date:  2015-10-24       Impact factor: 4.497

5.  Hydroxylamine-Derived Reagent as a Dual Oxidant and Amino Group Donor for the Iron-Catalyzed Preparation of Unprotected Sulfinamides from Thiols.

Authors:  Sayanti Chatterjee; Szabolcs Makai; Bill Morandi
Journal:  Angew Chem Int Ed Engl       Date:  2020-11-10       Impact factor: 16.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.